An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy Y Chen, R Xia, Y Huang, W Zhao, J Li, X Zhang, P Wang, ... Nature communications 7 (1), 13443, 2016 | 185 | 2016 |
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy J Sun, Y Liu, Y Chen, W Zhao, Q Zhai, S Rathod, Y Huang, S Tang, ... Journal of Controlled Release 258, 43-55, 2017 | 114 | 2017 |
Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel J Lu, Y Huang, W Zhao, Y Chen, J Li, X Gao, R Venkataramanan, S Li Molecular pharmaceutics 10 (8), 2880-2890, 2013 | 80 | 2013 |
Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier J Sun, Y Chen, Y Huang, W Zhao, Y Liu, R Venkataramanan, B Lu, S Li Acta Pharmacologica Sinica 38 (6), 823-834, 2017 | 73 | 2017 |
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel X Zhang, J Lu, Y Huang, W Zhao, Y Chen, J Li, X Gao, ... Bioconjugate chemistry 24 (3), 464-472, 2013 | 70 | 2013 |
Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy L Chen, R Sun, J Xu, W Zhai, D Zhang, M Yang, C Yue, Y Chen, S Li, ... Cancer immunology research 8 (11), 1381-1392, 2020 | 47 | 2020 |
Targeted Delivery of Curcumin to Tumors via PEG-Derivatized FTS-Based Micellar System Y Chen, X Zhang, J Lu, Y Huang, J Li, S Li The AAPS journal 16, 600-608, 2014 | 47 | 2014 |
A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel J Sun, Y Chen, K Li, Y Huang, X Fu, X Zhang, W Zhao, Y Wei, L Xu, ... Acta biomaterialia 43, 282-291, 2016 | 45 | 2016 |
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel X Zhang, Y Huang, W Zhao, Y Chen, P Zhang, J Li, R Venkataramanan, ... Molecular pharmaceutics 11 (8), 2807-2814, 2014 | 44 | 2014 |
Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy J Sun, Z Wan, Y Chen, J Xu, Z Luo, RA Parise, D Diao, P Ren, JH Beumer, ... Acta biomaterialia 106, 289-300, 2020 | 42 | 2020 |
Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis Y Chen, J Sun, Y Huang, Y Liu, L Liang, D Yang, B Lu, S Li Nanomedicine: Nanotechnology, Biology and Medicine 15 (1), 129-141, 2019 | 35 | 2019 |
Lymphoma immunochemotherapy: targeted delivery of doxorubicin via a dual functional nanocarrier Q Zhai, Y Chen, J Xu, Y Huang, J Sun, Y Liu, X Zhang, S Li, S Tang Molecular Pharmaceutics 14 (11), 3888-3895, 2017 | 31 | 2017 |
High loading of hydrophobic and hydrophilic agents via small immunostimulatory carrier for enhanced tumor penetration and combinational therapy J Sun, Y Chen, J Xu, X Song, Z Wan, Y Du, W Ma, X Li, L Zhang, S Li Theranostics 10 (3), 1136, 2020 | 29 | 2020 |
Improved cancer immunochemotherapy via optimal co-delivery of chemotherapeutic and immunomodulatory agents Y Chen, J Sun, Y Huang, B Lu, S Li Molecular pharmaceutics 15 (11), 5162-5173, 2018 | 22 | 2018 |
PEG-Fmoc-ibuprofen conjugate as a dual functional nanomicellar carrier for paclitaxel M Zhao, Y Huang, Y Chen, J Xu, S Li, X Guo Bioconjugate Chemistry 27 (9), 2198-2205, 2016 | 19 | 2016 |
Improved micellar formulation for enhanced delivery for paclitaxel J Xu, X Zhang, Y Chen, Y Huang, P Wang, Y Wei, X Ma, S Li Molecular pharmaceutics 14 (1), 31-41, 2017 | 17 | 2017 |
Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid Y Liu, J Sun, Y Huang, Y Chen, J Li, L Liang, J Xu, Z Wan, B Zhang, Z Li, ... Biochemical pharmacology 189, 114453, 2021 | 16 | 2021 |
A nanomicellar prodrug carrier based on ibuprofen-conjugated polymer for co-delivery of doxorubicin Z Li, J Sun, Y Huang, Y Liu, J Xu, Y Chen, L Liang, J Li, Q Liao, S Li, ... Frontiers in pharmacology 9, 781, 2018 | 14 | 2018 |